Page last updated: 2024-10-19

oxaloacetic acid and Stroke

oxaloacetic acid has been researched along with Stroke in 2 studies

Oxaloacetic Acid: A dicarboxylic acid ketone that is an important metabolic intermediate of the CITRIC ACID CYCLE. It can be converted to ASPARTIC ACID by ASPARTATE TRANSAMINASE.
oxaloacetic acid : An oxodicarboxylic acid that is succinic acid bearing a single oxo group.

Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teichberg, VI1
Campos, F1
Sobrino, T1
Ramos-Cabrer, P1
Castillo, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors[NCT04592354]40 participants (Anticipated)Interventional2020-10-15Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for oxaloacetic acid and Stroke

ArticleYear
Oxaloacetate: a novel neuroprotective for acute ischemic stroke.
    The international journal of biochemistry & cell biology, 2012, Volume: 44, Issue:2

    Topics: Animals; Brain; Brain Ischemia; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Nerve Dege

2012

Other Studies

1 other study available for oxaloacetic acid and Stroke

ArticleYear
GOT to rid the body of excess glutamate.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2011, Volume: 31, Issue:6

    Topics: Animals; Aspartate Aminotransferases; Brain; Glutamic Acid; Humans; Neuroprotective Agents; Oxaloace

2011